About

Learn more about our mission and team.

Mission

Our mission is to transform the standard of care for hypertrophic cardiomyopathy and related conditions.

[data-wf-bgvideo-fallback-img] { display: none; } @media (prefers-reduced-motion: reduce) { [data-wf-bgvideo-fallback-img] { position: absolute; z-index: -100; display: inline-block; height: 100%; width: 100%; object-fit: cover; } }

About Us

Braveheart’s team represents an accomplished, mission-driven group of people committed to advancing care for patients.

Leadership

Travis Murdoch, M.D.

Chief Executive Officer

Michele Anderson

Chief Development Officer

Marc Evanchik, M.S.

Chief Scientific Officer

Chief Financial Officer

Brittany de Temple

Senior Vice President, Development Operations

Team

Lee Bockus, M.D., Ph.D.

Jennifer Brooks

Sara Butler

Natalie Dement, J.D.

Joanne Dill

Amy Feng, Ph.D.

Mark Henderson, Ph.D.

Matt Kelly

Eddie Kim

Garland Lee, Pharm.D.

Caspar Lin

Ali Moulton

Kelly Mumma

Steph Palencia

Niki Patel, Pharm.D.

Chris Peters

Peter Riebling

Arian Zari

Tim Zhou

Board of Directors

Chris Viehbacher

Chair of the Board

Jasper Bos, Ph.D.

Board Director

Erez Chimovits, M.B.A., M.Sc.

Board Director

Jason Coloma, Ph.D., M.B.A.

Board Director

Tim Lohoff, Ph.D.

Board Director

David Malek, MBA

Board Director

Vineeta Agarwala, M.D., Ph.D.

Board Observer

Evan Caplan, M.D., M.B.A.

Board Observer

Neel Varshney, M.D.

Board Observer

Investors

[data-wf-bgvideo-fallback-img] { display: none; } @media (prefers-reduced-motion: reduce) { [data-wf-bgvideo-fallback-img] { position: absolute; z-index: -100; display: inline-block; height: 100%; width: 100%; object-fit: cover; } }

Interested in joining our team?

Learn more about our openings.